Jean‐Paul Soulillou

Author

Jean‐Paul Soulillou

Also Known As

D Grant, J -P. Soulillou, J P Soulillou, J P. Soulillou, J Soulillou, J. -P. Soulillou, J. P. SOULILLOU, J. P. Soulillou, J. Soulillou, J.-P Soulillou

476

Publications

15.9K

Citations

H-Index

202

Concepts

All Affiliations

Inserm Institut de Transplantation Urologie en Nephrologie Nantes Université Centre Hospitalier Universitaire de Nantes Centre d'Investigation Clinique de Nantes

About

Jean‐Paul Soulillou is an author at Inserm specializing in medicine, immunology, and transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	51	105	9.1K
2	Health Sciences	3	3	113
3	Engineering	1	1	66
4	Language Studies	1	1	10
5	Natural Sciences	1	1	12

Jean‐Paul Soulillou

212

Publications

14K

Citations

H-Index

Page 1

	Year	Citations
Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients Björn Nashan, Richard H. Moore, P L Amlot, The Lancet Transplant RejectionUrologyTransplantationAcute Cellular RejectionKidney Transplant	1997	761
Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens Jacques Dantal, Maryvonne Hourmant, Diego Cantarovich, The Lancet Transplant RejectionUrologyTransplantationKidney TransplantMedicine	1998	742
Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans Pervinder Sagoo, Esperanza Perucha, Birgit Sawitzki, Journal of Clinical Investigation Cross-platform Biomarker SignatureImmune ToleranceTransplant RecipientsSolid Organ TransplantationImmunology	2010	515
Each additional hour of cold ischemia time significantly increases the risk of graft failure and mortality following renal transplantation A. Debout, Yohann Foucher, Katy Trébern-Launay, Kidney International TransplantationKidney TransplantKidney TransplantationChronic Kidney DiseaseCold Ischemia Time	2014	369
Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance Sophie Brouard, Elaine Mansfield, Christophe Braud, Proceedings of the National Academy of Sciences Gene SignatureInvasive Blood BiomarkersImmunologyImmunotherapyTranslational Medicine	2007	363
Frequency and Clinical Implications of Development of Donor-Specific and Non–Donor-Specific HLA Antibodies after Kidney Transplantation Maryvonne Hourmant, Anne Cesbron‐Gautier, Paul I. Terasaki, Journal of the American Society of Nephrology HlaHistocompatibilityClinical ImplicationsImmunologyYr Posttransplantation	2005	292
Contrasting CD25hiCD4+T Cells/FOXP3 Patterns in Chronic Rejection and Operational Drug-Free Tolerance St phanie Louis, Cécile Braudeau, Magali Giral, Transplantation	2006	271
Patients with drug-free long-term graft function display increased numbers of peripheral B cells with a memory and inhibitory phenotype Annaïck Pallier, Sophie Hillion, Richard Danger, Kidney International Regenerative MedicineCell TherapyTransplantationStem Cell TransplantationImmunology	2010	267
Delayed graft function of more than six days strongly decreases long-term survival of transplanted kidneys Magali Giral‐Classe, Maryvonne Hourmant, Diego Cantarovich, Kidney International UrologyTransplantationKidney TransplantTransplanted KidneysKidney Transplantation	1998	235
Expression and release of soluble HLA-E is an immunoregulatory feature of endothelial cell activation Stéphanie Coupel, M. Hamidou, Václav Hořejšı́, Blood	2006	188

Page 1